ClearPoint Neuro (NASDAQ:CLPT), a medical-device company that provides navigation and delivery systems for brain therapies, advanced 11.80% as investors revisited a stock that has straddled the line between promising platform play and cash-burning small cap.
Cadiz, Inc. (NASDAQ:CDZI), a California land and water-resources company, rose 9.81% as investors continued to reward progress on its long-gestating plan to move water across the Mojave Desert. The move extended a run of enthusiasm sparked by a pivotal federal approval earlier in the …
C1 Fund (NYSE:CFND), a closed-endInvestmentvehicle focused on late-stage private companies in financial services, digital assets and technology, jumped 10.98% in a session that briefly returned the small fund stock to traders' watchlists. The move stands out because CFND has spent much of the past …
Shares of Biodesix (NASDAQ:BDSX), the Colorado-based lung-diagnostics company, jumped 10.58% in a session that put the small-cap name back on the radar of momentum traders and healthcare investors alike. The move came against a backdrop of steadily improving fundamentals, with the company reporting rapid …
Beam Therapeutics (NASDAQ:BEAM) rose 9.53% as gene-editing stocks found renewed momentum and the company advanced its lead base-editing program into a pivotal-stage cohort, reviving interest in a technology that promises precise, single-letter corrections to DNA.
● BIAF shares fell 10.82% without an accompanying negative disclosure, running counter to the company's recently reported operational momentum.
Bit Origin (NASDAQ:BTOG) gained 9.04% as the small-cap company's transformation into a Dogecoin-focused treasury vehicle kept it firmly tied to crypto sentiment. Once known primarily as a bitcoin-mining and infrastructure play, Bit Origin has repositioned around accumulating the meme-linked token, and its stock now …
● CDT shares slid 17.67% with no fresh, verifiable news catalyst, extending a decline that has erased roughly 99% ofShareholdervalue over the trailing twelve months.
● AMOD shares fell nearly 19% after the company secured a new $10 millionEquity Financingarrangement and registered several million resale shares.
● ARKR shares fell 11.90% directly following fiscal third-quarter 2026 earnings, released in mid-August, which showed a year-over-yearRevenuedecline and weaker profitability.